HIGHLIGHTS
- who: Shu Wang from the Department of, Shengjing Hospital of China Medical University, China, Department of Clinical have published the paper: DHW-208, A Novel Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Has Anti-Hepatocellular Carcinoma Activity Through Promoting Apoptosis and Inhibiting Angiogenesis, in the Journal: (JOURNAL) of 29/05/2022
- what: DHW-208 is candidate compound to be developed as small molecule PI3K inhibitor for the treatment of HCC and the study provides certain theoretical basis for the treatment of HCC and the development of PI3K inhibitors. Based on this research progress of PI3K inhibitors, the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.